Export

Vertex Pharmaceuticals (Sweden) AB

Financial information

The information source is the annual report of the company with business id 556991-2024

* Closing information (×1000) SEK

Fiscal year 202312 202212
Number of months: 12 12
Turnover: 58,242 Revenue Up 51,614 Revenue Up
Financial expenses: 332 Revenue Up 114 Revenue Up
Earnings before taxes: 3,832 Revenue Up 3,457 Revenue Up
Total assets: 32,610 Revenue Down 65,540 Revenue Up
Current assets: 32,342 Revenue Down 64,752 Revenue Up
Current liabilities: 16,250 Revenue Down 52,004 Revenue Up
Equity capital: 16,360 Revenue Up 13,536 Revenue Up
Share capital: 50 50
Number of employees: 9 Revenue Up 7

Financial ratios

Solvency: 50.2% Revenue Up 20.7% Revenue Down
Turnover per employee: 6,471 Revenue Down 7,373 Revenue Up
Profitability: 6.6% Revenue Down 6.7% Revenue Down
Return on equity (ROE): 23.4% Revenue Down 25.5% Revenue Down
Current ratio: 199.0% Revenue Up 124.5% Revenue Down
Return on assets (ROA): 12.8% Revenue Up 5.4% Revenue Down
Fiscal year 202312
Number of months: 12
Turnover: 58,242
Financial expenses: 332
Earnings before taxes: 3,832
Total assets: 32,610
Current assets: 32,342
Current liabilities: 16,250
Equity capital: 16,360
Share capital: 50
Number of employees: 9

Financial ratios

Solvency: 50.2%
Turnover per employee: 6,471
Profitability: 6.6%
Return on equity (ROE): 23.4%
Current ratio: 199.0%
Return on assets (ROA): 12.8%